ASH – 2021 – Poster Presentation 1716
Publications
December 11, 2021
G-CSF/Plerixafor Dual-Mobilized Donor Derived CD33CAR T-Cells as Potent and Effective AML Therapy in Pre-Clinical Models
Platform, VCAR33
Presented by: Giacomo Canesin, PhD – Preclinical and Translational Biology – Vor Bio